Updated Jul 16, 2026 · Last SEC filing 2026-06-22
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) has filed 28 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-22. 2 Form 8-K material event filings were reported by TEVA in the last 90 days. 9 Form 144 notices of proposed sale were filed for TEVA stock. InsiderAlpha tracks every TEVA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0000818686 |
|---|
| Form 4 filings (90d) | 28 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 9 |
| Latest Form 4 filing | 2026-06-22 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Shields Matthew | EVP, Global Operations | S — Open-market sale | 10.0K | $32.19 | $322K | SEC | |
| Kalif Eliyahu Sharon | EVP, Chief Financial Officer | S — Open-market sale | 106.6K | $34.10 | $3.63M | SEC | |
| Francis Richard D | President and CEO | S — Open-market sale | 6.2K | $34.35 | $211K | SEC | |
| Zaks Tal Zvi | Insider | M — Option exercise | 14.5K | — | — | SEC | |
| Lichtenstein Chen | Insider | M — Option exercise | 14.5K | — | — | SEC | |
| BARER SOL J | Insider | M — Option exercise | 21.7K | — | — | SEC | |
| Crane Rosemary A | Insider | M — Option exercise | 14.5K | — | — | SEC | |
| Elstein Amir | Insider | M — Option exercise | 14.5K | — | — | SEC | |
| Nisen Perry | Insider | M — Option exercise | 14.5K | — | — | SEC | |
| LIEBERMAN GERALD M | Insider | M — Option exercise | 14.5K | — | — | SEC | |
| Satchi-Fainaro Ronit | Insider | M — Option exercise | 14.5K | — | — | SEC | |
| Francis Richard D | President and CEO | M — Option exercise | 13.0K | — | — | SEC | |
| MIGNONE ROBERTO | Insider | M — Option exercise | 14.5K | — | — | SEC | |
| Shields Matthew | EVP, Global Operations | S — Open-market sale | 16.2K | $32.87 | $532K | SEC | |
| Shields Matthew | EVP, Global Operations | M — Option exercise | 16.2K | — | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Lippman Evan | 6 | $1.48M |
| Shields Matthew | 4 | $854K |
| MIGNONE ROBERTO | 3 | — |
| LIEBERMAN GERALD M | 3 | — |
| BARER SOL J | 3 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in TEVA insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live TEVA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.